Presentation TCT 2014 Position Statement: Heparin Will Once Again Become the Anticoagulant of Choice for PCI in Stable and Unstable Coronary Syndromes Presenter: Michael S. Lee September 14, 2014 REGISTER for free or LOG IN to view this content CAD Pharma ACS/AMI Presentation TCT 2014 Up Next Presentation TCT 2014 Valvular Heart Disease: Aortic Valvuloplasty and TAVR Presenter: Jason Kovacic September 14, 2014 More slides + Presentation TCT 2014 Retrograde Aortic Approach with Pledgets (Mitalign) The CE Mark Study Presenter: Alexandre Abizaid September 14, 2014 Presentation TCT 2014 CardiaQ: Design, Clinical Results, and Next Steps Presenter: Lars Sondergaard September 14, 2014 We Recommend
Presentation TCT 2014 Valvular Heart Disease: Aortic Valvuloplasty and TAVR Presenter: Jason Kovacic September 14, 2014
Presentation TCT 2014 Retrograde Aortic Approach with Pledgets (Mitalign) The CE Mark Study Presenter: Alexandre Abizaid September 14, 2014
Presentation TCT 2014 CardiaQ: Design, Clinical Results, and Next Steps Presenter: Lars Sondergaard September 14, 2014